Dalgleish, A.
St George's, University of London
4 papers on CoChatORCID 0000-0003-3511-3059
Most cited papers
- Verified
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics
Cancer, Hypoxia, and MetabolismAdrenal and Paraganglionic Tumors
Cited by 865
- Verified
In vivo cellular tropism of human T-cell leukemia virus type 1
Richardson, J. H., Edwards, A. J., Cruickshank, J. K., Rudge, P., & Dalgleish, A. G. (1990) · Journal of Virology
T-cell and Retrovirus StudiesHepatitis B Virus Studies
Cited by 429
- Verified
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Dalgleish, A. G., Stebbing, J., Adamson, D. J., Arif, S. S., Bidoli, P., Chang, D., Cheeseman, S., Diaz-Beveridge, R., Fernandez-Martos, C., Glynne-Jones, R., et al. (2016) · British Journal of Cancer
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 75
- Verified
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
Stebbing, J., Dalgleish, A., Gifford-Moore, A., Martin, A., Gleeson, C., Wilson, G., Brunet, L. R., Grange, J., & Mudan, S. (2012) · Annals of Oncology
Cutaneous Melanoma Detection and ManagementImmunotherapy and Immune Responses
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free